Form D — Terremoto Biosciences, Inc.
0001231919-26-000386 · filed Apr 22, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $108,599,999
- Total sold
- $40,725,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Terremoto Biosciences, Inc.
- CIK
- 2130748
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 230 EAST GRAND AVENUE, SUITE 200
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 415-535-2787
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Charles Baum · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
James Christensen · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Grace Lu · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Reid Huber · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Daniel O'Connell · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Peter Thompson · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Michael Goller · DirectorSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗